Literature DB >> 15378857

Coumarins from Cnidium monnieri (L.) and their proliferation stimulating activity on osteoblast-like UMR106 cells.

F Meng1, Z Xiong, Y Sun, F Li.   

Abstract

The proliferation of various fractions of alcoholic extracts from fruits of Cnidium monnieri (L.) Cuss (umbelifera) were screened using the osteoblast-like UMR106 cells in vitro. The chloroform fraction from the crude extract was found to have the most stimulating activity. Three coumarins (osthole, bergapten and imperatorin) were isolated from this fraction by activity-guided assay, and their effects on osteoblastic proliferation were investigated. Osthole, a major pharmacologically active constituent, significantly promoted the cells' activity. Bergapten and imperatorin were less effective than osthole. These results suggested Cnidium monnieri (L.) Cuss extracts might have potential activity against osteoporosis, and its chloroform fraction might contain active constituents stimulating osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378857

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  12 in total

1.  Bergapten promotes bone marrow stromal cell differentiation into osteoblasts in vitro and in vivo.

Authors:  Ji-jie Xiao; Wen-ji Zhao; Xin-tao Zhang; Wen-long Zhao; Xiao-xia Wang; Shu-hui Yin; Fang Jiang; Yin-xia Zhao; Fang-ni Chen; Shao-lin Li
Journal:  Mol Cell Biochem       Date:  2015-07-19       Impact factor: 3.396

2.  Inhibition of osteolysis after local administration of osthole in a TCP particles-induced osteolysis model.

Authors:  Shumin Lv; Yun Zhang; Ming Yan; Hongjiao Mao; Cailing Pan; Mingxiao Gan; Jiawen Fan; Guoxia Wang
Journal:  Int Orthop       Date:  2015-10-26       Impact factor: 3.075

3.  Bergapten prevents lipopolysaccharide mediated osteoclast formation, bone resorption and osteoclast survival.

Authors:  Mingxia Zheng; Yongliang Ge; Haiyu Li; Ming Yan; Jin Zhou; Yun Zhang
Journal:  Int Orthop       Date:  2013-12-04       Impact factor: 3.075

4.  Osthole stimulates osteoblast differentiation and bone formation by activation of beta-catenin-BMP signaling.

Authors:  De-Zhi Tang; Wei Hou; Quan Zhou; Minjie Zhang; Jonathan Holz; Tzong-Jen Sheu; Tian-Fang Li; Shao-Dan Cheng; Qi Shi; Stephen E Harris; Di Chen; Yong-Jun Wang
Journal:  J Bone Miner Res       Date:  2010-06       Impact factor: 6.741

5.  The importance of the prenyl group in the activities of osthole in enhancing bone formation and inhibiting bone resorption in vitro.

Authors:  Yuan-Kun Zhai; Ya-Lei Pan; Yin-Bo Niu; Chen-Rui Li; Xiang-Long Wu; Wu-Tu Fan; Ting-Li Lu; Qi-Bing Mei; Cory J Xian
Journal:  Int J Endocrinol       Date:  2014-07-24       Impact factor: 3.257

6.  Effect of Semelil, an Herbal Selenium-Based Medicine, on New Bone Formation in Calvarium of Rabbits.

Authors:  Amir Alireza Rasouli-Ghahroudi; Amirreza Rokn; Mohammad Abdollahi; Fatemeh Mashhadi-Abbas; Siamak Yaghobee
Journal:  Biomed Res Int       Date:  2018-02-26       Impact factor: 3.411

7.  Osthole Enhances Osteogenesis in Osteoblasts by Elevating Transcription Factor Osterix via cAMP/CREB Signaling In Vitro and In Vivo.

Authors:  Zhong-Rong Zhang; Wing Nang Leung; Gang Li; Siu Kai Kong; Xiong Lu; Yin Mei Wong; Chun Wai Chan
Journal:  Nutrients       Date:  2017-06-08       Impact factor: 5.717

8.  Osthole inhibits bone metastasis of breast cancer.

Authors:  Chunyu Wu; Zhenping Sun; Baofeng Guo; Yiyi Ye; Xianghui Han; Yuenong Qin; Sheng Liu
Journal:  Oncotarget       Date:  2017-04-11

Review 9.  Botanical Sources, Chemistry, Analysis, and Biological Activity of Furanocoumarins of Pharmaceutical Interest.

Authors:  Renato Bruni; Davide Barreca; Michele Protti; Virginia Brighenti; Laura Righetti; Lisa Anceschi; Laura Mercolini; Stefania Benvenuti; Giuseppe Gattuso; Federica Pellati
Journal:  Molecules       Date:  2019-06-08       Impact factor: 4.411

10.  Induction of apoptosis of human primary osteoclasts treated with extracts from the medicinal plant Emblica officinalis.

Authors:  Letizia Penolazzi; Ilaria Lampronti; Monica Borgatti; Mahmud Tareq Hassan Khan; Margherita Zennaro; Roberta Piva; Roberto Gambari
Journal:  BMC Complement Altern Med       Date:  2008-10-30       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.